OncoCyte's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
OncoCyte (NASDAQ:OCX) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-1.01. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price. The stock is currently trading at $2.33, down 81.68% over the last 52-week period.
November 08, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
OncoCyte's upcoming earnings report could impact its stock price. The company has a history of beating EPS estimates but experiencing a drop in share price.
OncoCyte's earnings report is a key event that could influence its stock price. The company's history of beating EPS estimates but experiencing a drop in share price suggests that investors may have concerns about its financial performance. The stock's significant decline over the past year also indicates bearish sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100